Pelvic Exenteration: An Updated Mini-Review from 1948 to 2020
DOI:
https://doi.org/10.15584/ejcem.2019.4.10Keywords:
complications, indications, morbidity, mortality, pelvic exenterationAbstract
Introduction. Pelvic exenteration (PE) is a curative or palliative radical surgical procedure applied for advanced or recurrent pelvic or perineal cancers. From 1948 to date, improvements in surgical techniques, including urinary conduits and pelvic reconstruction, have improved its morbidity and mortality.
Aim. The present study reviews the evolution of PE, indications, complications and current results.
Material and methods. Large case series and studies on PE were searched in PubMed, covering all years available, and recent applications of PE were reviewed.
Analysis of the literature. Indications of PE are primary or locally advanced tumors (cervix. rectum. vulva. bladder), recurrence after radiotherapy (cervix), recurrence after primary resection (vulva, vagina, cervix, rectum) and palliative treatment for advanced tumors or pubic fistulas. Contraindication are distant metastases, involvement of iliac vessels, pelvic side-wall or para-aortic lymph nodes and invasion of sacrum proximal to S1/S2 or sciatic foramen. However, recent studies have reported more radical resections, including side-wall and vessels. Patient’s health condition and fitness are also important in decision-making.
Conclusion. PE can be the last chance of cure or improving quality of life for advanced or locally recurrent pelvic cancers. 5-year survival rates with PE are better, but complications of such a radical surgery are still high, and should be improved.
Downloads
References
Brown KGM, Solomon MJ, Koh CE. Pelvic exenteration surgery: The evolution of radical surgical techniques for advanced and recurrent pelvic malignancy. Dis Colon Rectum. 2017;60:745-754.
Bacalbasa N, Balescu I. Pelvic exenteration - reconsidering the procedure. J Med Life. 2015;8:146-149.
Peacock O, Waters PS, Kong JC, et al. Complications after extended radical resections for locally advanced and recurrent pelvic malignancies: A 25-year experience. Ann Surg Oncol. 2019. doi: 10.1245/s10434-019-07816-8.
Waters PS, Peacock O, Warrier SK, et al. Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades. Eur J Surg Oncol. 2019. doi: 10.1016/j.ejso.2019.07.015.
Bogani G, Signorelli M, Ditto A, et al. Factors Predictive of 90-day morbidity, readmission, and costs in patients undergoing pelvic exenteration. Int J Gynecol Cancer. 2018;28:975-982.
Platt E, Dovell G, Smolarek S. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Tech Coloproctol. 2018;22:835-845.
Diver EJ, Rauh-Hain JA, del Carmen MG. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol. 2012; 2012: 693535.
Ferenschild FT, Vermaas M, Verhoef C, et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009;33:1502-1508.
Kato K, Omi M, Fusegi A, Takeshima N. Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer. Gynecol Oncol. 2019. doi: 10.1016/j.ygyno.2019.07.015.
Vizzielli G, Naik R, Dostalek L, et al. Laterally extended pelvic resection for gynaecological malignancies: A multicentric experience with out-of-the-box surgery. Ann Surg Oncol. 2019;26(2):523-530.
Martínez-Gómez C, Angeles MA, Martinez A, Ferron G. Laparoscopic anterior pelvic exenteration in 10 steps. Gynecol Oncol. 2018;150:201-202.
Berretta R, Marchesi F, Volpi L, et al. Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome. Taiwan J Obstet Gynecol. 2016;55:346-350.
Konstantinidis IT, Chu W, Tozzi F, et al. Robotic total pelvic exenteration: Video-illustrated technique. Ann Surg Oncol. 2017;24:3422-3423.
Sasikumar A, Bhan C, Jenkins JT, Antoniou A, Murphy J. Systematic review of pelvic exenteration with en bloc sacrectomy for recurrent rectal adenocarcinoma: R0 resection predicts disease-free survival. Dis Colon Rectum. 2017;60(3):346-352.
Kim HS, Kim R, Lee M. Super-radical hysterectomy for recurrent cervical cancer. Surg Oncol. 2017;26:331-332.
Solomon MJ, Brown KG, Koh CE, Lee P, Austin KK, Masya L. Lateral pelvic compartment excision during pelvic exenteration. Br J Surg. 2015;102:1710-1717.
Höckel M. Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol. 2006;32:859-865.
Brown KG, Koh CE, Solomon MJ, Qasabian R, Robinson D, Dubenec S. Outcomes after en bloc iliac vessel excision and reconstruction during pelvic exenteration. Dis Colon Rectum. 2015;58:850-856.
Yang Q, Tang J, Xiao L. Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report. Medicine (Baltimore). 2018;97:e11611.
Uehara K, Nakamura H, Yoshino Y, et al. Initial experience of laparoscopic pelvic exenteration and comparison with conventional open surgery. Surg Endosc. 2016;30:132-138.
Ogura A, Akiyoshi T, Konishi T, et al. Safety of Laparoscopic Pelvic Exenteration with Urinary Diversion for Colorectal Malignancies. World J Surg. 2016;40:1236-1243.
Kathopoulis N, Thomakos N, Mole I, Papaspirou I, Ntai S, Rodolakis A. Anterior pelvic exenteration for exstrophic bladder adenocarcinoma: Case report and review. Int J Surg Case Rep. 2016;25:13-15.
Minar L, Felsinger M, Rovny I, Zlamal F, Bienertova-Vasku J, Jandakova E. Modified posterior pelvic exenteration for advanced ovarian malignancies: a single-institution study of 35 cases. Acta Obstet Gynecol Scand. 2017;96:1136-1143.
Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J. Locally advanced rectal cancer: management challenges. Onco Targets Ther. 2016;9:6265-6272.
Gawad W, Khafagy M, Gamil M, Fakhr I, Negm M, Mokhtar N, Lotayef M, Mansour O. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer. J Egypt Natl Canc Inst. 2014;26:167-173.
Tatar B, Yalçın Y, Erdemoğlu E. Palliative pelvic exenteration using iliofemoral bypass with synthetic grafts for advanced cervical carcinoma. Turk J Obstet Gynecol. 2019;16:80-83.
Kaufmann OG, Young JL, Sountoulides P, Kaplan AG, Dash A, Ornstein DK. Robotic radical anterior pelvic exenteration: the UCI experience. Minim Invasive Ther Allied Technol. 2011;20:240-246.
Waters WB, Vaughan DJ, Harris RG, Brady SM. The Kock pouch: initial experience and complications. J Urol. 1987;137:1151-1153.
Souma T, Terai A, Arai Y, Hashimura T, Takeuchi H, Yoshida O. Continent urinary reservoir using sigmoid colon and appendix after pelvic exenteration for bulky leiomyosarcoma: a case report. J Urol. 1995;153:1907-1909.
Sanchez-Valdivieso E, Gonzalez Enciso A, Herrera Gomez A, Chavez-Montes de Oca V, Munoz Gonzalez D. Preliminary experience with the Miami type ileocolonic urinary reservoir in the practice of oncologic gynecology. Arch Esp Urol. 2001;54:327-333.
Singh M, Kinsley S, Huang A, et al. Gracilis flap reconstruction of the perineum: An outcomes analysis. J Am Coll Surg. 2016;223:602-610.
Qiu SS, Jurado M, Hontanilla B. Comparison of TRAM versus DIEP flap in total vaginal reconstruction after pelvic exenteration. Plast Reconstr Surg. 2013;132:1020e-1027e.
Tortorella L, Casarin J, Mara KC, et al. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol. 2019;152:151-156.
Wydra D, Emerich J, Sawicki S, Ciach K, Marciniak A. Major complications following exenteration in cases of pelvic malignancy: A 10-year experience. World J Gastroenterol. 2006;12:1115-1119.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
